This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rigsby, P.
Right arrow Articles by Gaines Das, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rigsby, P.
Right arrow Articles by Gaines Das, R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2004, p. 5133-5138, Vol. 42, No. 11
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.11.5133-5138.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Evaluation of a Candidate International Standard Preparation for Human Anti-Toxoplasma Immunoglobulin G

Peter Rigsby,1 Sjoerd Rijpkema,2* Edward C. Guy,3 Janet Francis,3 and Rose Gaines Das1

Informatics Laboratory,1 Division of Bacteriology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire,2 Toxoplasma Reference Laboratory, National Public Health Service for Wales, Swansea, United Kingdom3

Received 14 April 2004/ Returned for modification 13 June 2004/ Accepted 26 July 2004

A freeze-dried human serum preparation containing immunoglobulin G (IgG) to Toxoplasma gondii was assessed for its suitability as an international reference reagent in an international collaborative study by 24 laboratories from 17 countries. This candidate standard was compared with the third international standard (IS) for human anti-Toxoplasma serum, TOXM, with the previous second IS, TOXS, and with a range of other serum samples. Samples were tested with the Sabin-Feldman dye test and a range of agglutination assays and enzyme immunoassays. This study emphasizes the need for appropriate standards if intermethod agreement of estimates is to be achieved. On the basis of the results of this study, the preparation was established by the World Health Organization as the first IS for human anti-Toxoplasma IgG, with an assigned potency of 20 IU per ampoule of total anti-Toxoplasma antibodies.

* Corresponding author. Mailing address: Division of Bacteriology, NIBSC, Blanche Lane, South Mimms, Potters Bar EN6 3QG, United Kingdom. Phone: 44 1707 641 000. Fax: 44 1707 663 796. E-mail: srijpkem{at}nibsc.ac.uk.

Journal of Clinical Microbiology, November 2004, p. 5133-5138, Vol. 42, No. 11
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.11.5133-5138.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Maudry, A., Chene, G., Chatelain, R., Patural, H., Bellete, B., Tisseur, B., Hafid, J., Raberin, H., Beretta, S., Tran Manh Sung, R., Belot, G., Flori, P. (2009). Bicentric Evaluation of Six Anti-Toxoplasma Immunoglobulin G (IgG) Automated Immunoassays and Comparison to the Toxo II IgG Western Blot. CVI 16: 1322-1326 [Abstract] [Full Text]  
  • Gomez-Morales, M. A., Ludovisi, A., Amati, M., Cherchi, S., Pezzotti, P., Pozio, E. (2008). Validation of an Enzyme-Linked Immunosorbent Assay for Diagnosis of Human Trichinellosis. CVI 15: 1723-1729 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»